Blog

These blog posts explore GP2’s work in further understanding the genetic architecture of Parkinson’s disease.

results.
  • Open Science Opens Doors

    By Bradford Casey | GP2 Values |

    In GP2, underlying data, analytical processes, and results will be made available to the research community as quickly as possible, with minimal barriers to access and use. The latest blog post by Bradford Casey highlights the value and importance of open science.

  • A letter to the patient community from Randy Schekman, ASAP Scientific Director

    By Randy Schekman and Benjamin Stecher | GP2 Values |

    ASAP Scientific Director, Randy Schekman, expresses his personal and professional connection with Parkinson's disease in a letter to the patient community, shared by patient advocate Benjamin Stecher.

  • A Blueprint for Training and Development in GP2

    By Alastair Noyce and Sara Bandres-Ciga | GP2 Values |

    Training is a crucial element of GP2. In this blog post, Alastair Noyce, Sara Bandres-Ciga and Emily Fisher outline the program's training and development goals.

  • Why study disease in different populations?

    By Ignacio Fernandez Mata | Complex disease genetics, GP2 Values |

    GP2 aims to revolutionize our understanding of the genetics of Parkinson's disease across populations. Ignacio 'Nacho' Mata explains the importance of involving populations currently underserved in disease research.

  • How to Blog

    By Simon Stott | Research communication |

    Simon Stott, founder of the Science of Parkinson's website and GP2 Working Group member, shares his tips for blogging in Parkinson's research.